In vivo 1H-NMR microimaging with respiratory triggering for monitoring adoptive immunotherapy of metastatic mouse lymphoma

Magnetic Resonance in Medicine

Volumn 38, Issue 3, 1997, Pages 440-455

  Fichtner, Klaus Peter ^a   Schirrmacher, Volker ^a   Griesbach, Andreas ^a   Hull, William E ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

1H MRI; Immunotherapy; Metastases; Mouse lymphoma

Indexed keywords

FIBER OPTIC SENSORS; MAMMALS; ONCOLOGY; PATHOLOGY; SPINNING (FIBERS);

CONFIDENCE LEVELS; FIELD OF VIEWS; IMMUNOTHERAPY; METASTASES; METASTATIC DISEASE; MOUSE LYMPHOMA; MULTISLICE SPIN ECHOS; RESPIRATORY GATINGS;

SIGNAL TO NOISE RATIO;

ADOPTIVE IMMUNOTHERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFACT REDUCTION; DIAGNOSTIC VALUE; FEMALE; IMMUNE RESPONSE; LYMPHOMA; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; SIGNAL NOISE RATIO; TREATMENT OUTCOME; ANIMAL; ARTIFACT; BREATHING; DBA MOUSE; DISEASE COURSE; DISEASE MODEL; FOLLOW UP; KIDNEY TUMOR; LIVER TUMOR; LUNG TUMOR; METASTASIS; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ARTIFACTS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; IMMUNOTHERAPY, ADOPTIVE; KIDNEY NEOPLASMS; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHOMA; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MICE, INBRED DBA; RESPIRATION; TREATMENT OUTCOME;

EID: 0030612398     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.1910380313     Document Type: Article

References (41)

1. W. E. Hull, K-P. Fichtner, High-field NMR-imaging of tumor models. in "Magnetic Resonance Microscopy" (B. Blümich, W. Kuhn. Eds.), pp. 479-500, VCH, Weinheim, 1992.
2. B. Künnecke, E. J. Delikatny, P. Russell, J. C. Hunter, C. E. Mountford, Proton magnetic resonance and human cervical neoplasia. II. Ex vivo chemical-shift microimaging. J. Magn. Reson. B 104, 135-42 (1994).
3. S. K. Sarkar, R. K. Clark, R. E. Rycyna, M. A. Mattingly, R. Greig, 9.4-T NMR microimaging studies of hepatic metastases of human colorectal tumors in nude mice. Magn. Reson. Med. 12, 268-273 (1989).
4. S. K. Sarkar, M. A. Mattingly, T. Kline, R. Greig, 9.4-T imaging studies of human tumor xenografts in nude mice. Invest. Radiol. 23, 677-679 (1988).
5. M. Brauer, R. A. Towner, I. Renaud, E. G. Janzen, D. L. Foxall, In vivo proton nuclear magnetic resonance imaging and spectroscopy studies of halocurbon-induced liver damage. Magn. Reson. Med. 9, 229-239 (1989).
6. 31P double frequency tuned birdcage coils to study carbon tetrachloride-induced hepatotoxicity in rats. Magn. Reson. Imaging 10, 679-688 (1992).
7. G. A. Johnson, R. R. Maronpot, Magnetic resonance microscopy of chemically-induced liver foci. Toxicol. Pathol. 17, 613-616 (1989).
8. G. A. Johnson, M. B. Thompson, G. P. Cofer, D. Campen, R. R. Maronpot, Magnetic resonance imaging of hepatic neoplasms in the rat. Vet. Pathol. 26, 303-308 (1989).
9. Y. Qin, M. van Cauteren, M. Osteaux, G. Willems, Quantitative study of the growth of experimental hepatic tumors in rats by using magnetic resonance imaging. Int. J. Cancer 51, 665-670 (1992).
10. Y. Qin, M. van Cauteren, M. Osteaux, A. V. Schally, G. Willems, Inhibitory effect of somatostatin analogue RC-160 on the growth of hepatic metastases of colon cancer in rats: a study with magnetic resonance imaging. Cancer Res. 52, 6025-6030 (1992).
11. D. Dixon, G. A. Johnson, G. P. Cofer, L. W. Hedlund, R. R. Maronpol, Magnetic resonance imaging (MRI): a new tool in experimental toxicologic pathology. Toxicol. Pathol. 16, 386-389 (1988).
12. C. J. M. Melief, Tumor eradication by adoptive transfer of cytotoxic T lymphocytes. Adv. Cancer Res. 58, 143-175 (1992).
13. V. Schirrmacher, P. Beckhove, A. Krüger, M. Rocha, V. Umansky, K-P. Fichtner, W. E. Hull, U. Zangemeister-Wittke, A. Griesbach, K. Jurianz, P. von Hoegen, Effective immune rejection of advanced metastasized cancer. Int. J. Oncol. 6, 505-521 (1995).
14. V. Schirrmacher, Active Specific Immnnotherapy - a new modality of cancer treatment involving the patient's own immune system. Onkologie 16, 290-296 (1993).
15. 1H-NMR microimaging for monitoring adoptive immunotherapy in a mouse model: detection of metastases and their irradiation, in "Proc., SMR, 2nd Annual Meeting, 1994," p. 1334.
16. L. Larizza, V. Schirrmacher, E. Pflüger. Acquisition of high metastatic capacity after in vitro fusion of a non-metastatic tumor line with a bone-marrow derived macrophage. J. Exp. Med. 160, 1579-1584 (1984).
17. R. Benke, E. Lang, D. Komitowski, S. Muto, V. Schirrmacher, Changes in tumor cell adhesiveness affecting speed of dissemination and mode of metastatic growth. Invasion Metastasis 8, 159-176 (1988).
18. 31P-NMR spectroscopy; in vivo monitoring of the local anti-tumor effects of systemic immune cell transfer. Int. J. Cancer 66, 484-495 (1996).
19. U. Zangeineister-Wittke, V. Schirrmacher, Transfer of long-lasting tumor immunity by immune T cells from MHC-congenic mice: migration, survival and tumor protectivity of cytotoxic donor cells. Biotherapy 3, 319-329 (1991).
20. S. J. Wilson, I. M. Brereton, P. Hockings, W. Roffmann, D. M. Doddrell, Respiratory triggered imaging with an optical displacement sensor. Magn. Reson. Imaging 11, 1027-1032 (1993).
21. A. Haase, D. Matthaei, R. Bartkovski, E. Dühmke, D. Leibfritz, Inversion recovery snapshot FLASH MR imaging. J. Comput. Assist. Tomogr. 13, 1036 (1989).
22. W. S. Warren, Effects of arbitrary laser or NMR pulse shapes on population inversion and coherence. J. Chem. Phys. 81, 5437-5448 (1984).
23. J. Mao, T. H. Mareci, E. R. Andrew, Experimental study of optimal selective 180° radiofrequency pulses. J. Magn. Reson. 79, 1-10 (1988).
24. D. S. Moore, G. P. McCabe, "Introduction to the Practice of Statistics," W. H. Freeman & Co., New York, 1989
25. 19F NMR. Magn. Reson. Med. 29, 446-458 (1993).
26. S. M. Ronen, A. Volk, J. Mispelter, Comparative NMR study of a differentiated rat hepatoma and its dedifferentiated subclone cultered as spheroids and as implanted tumors. NMR Biomed. 7, 278-286 (1994).
27. N. G. Burdett, T. A. Carpenter, L. D. Hall, A simple device for respiratory gating for the MRI of laboratory animals. Magn. Reson. Imaging 11, 897-901 (1993).
28. S. K. Lemieux, G. H. Glover, An infrared device for monitoring the respiration of small rodents during magnetic resonance imaging. J. Magn. Reson. Imaging 6, 561-564 (1996).
29. T. P. Trouard, Y. Sabharwal, M. I. Altbach, A. F. Gmitro, Analysis and comparison of motion-correction techniques in diffusion-weighted imaging. J. Magn. Reson. Imaging 6, 925-935 (1996).
30. Y. Wang, R. G. Grimm, J. P. Felmlee, R. J. Riederer, R. L. Ehman, Algorithms for extracting motion information from navigator echoes. Magn. Reson. Med. 36, 117-123 (1996).
31. M. Louis Lauzon, B. K. Rutt, Generalized k-space analysis and correction of motion effects in MR imaging. Magn. Reson. Med. 30, 438-446 (1993).
32. A. M. Ulug, P. B. Barker, P. G. M. van Zijl, Correction of motional artifacts in diffusion-weighted images using a reference phase map. Magn. Reson. Med. 34, 476-480 (1995).
33. T. S. Sachs, C. H. Meyer, P. Irarrazabal, B. S. Hu, D. G. Nishimura, A. Macovski, The diminishing variance algorithm for real-time reduction of motion artifacts in MRI. Magn, Reson. Med. 34, 412-422 (1995).
34. Y. Wang, P. J. Rossman, R. C. Grimm, A. H. Wilman, S. J. Riederer, R. L. Ehman, 3D MR angiography of pulmonary arteries using real-time navigator gating and magnetization preparation. Magn. Reson. Med. 36, 579-587 (1996).
35. R.-I. Ernestus, L. J. Wilmes, M. Hoehn-Berlage, Identification of intracranial liqor metastases of experimental stereotactically implanted brain tumors by the tumor-selective MRI contrast agent MnTPPS. Clin. Exp. Metastasis 10, 345-350 (1992).
36. W. Negendank, T. Corbett, M. Crowley, C. Kellogg, Evidence for a contribution of paramagnetic ions to water proton spin-lattice relaxation in normal and malignant mouse tissues. Magn. Reson. Med. 18, 280-293 (1991).
37. B. P. Randazzo, S. Kesari, R. M. Gesser, D. Alsop, J. C. Ford, S. M. Brown, A. Maclean, N. W. Frase, Treatment of experimental murine melanoma with a neuroattenuated herpes simplex virus 1 mutant. Virology 211, 94-101 (1995).
38. M. Izquierdo, M. Cortes, P. de Felipe, V. Martin, J. Diez-Guerra, A. Talavera, A. Perez-Higueras, Long-term rat survival after malignant brain tumor regression by retroviral gene therapy. Gene Ther. 2, 66-69 (1995).
39. J. A. Coderre, T. M. Button, P. L. Micca, C. D. Fisher, M. M. Nawrocky, H. B. Liu, Neutron capture therapy of the 9L rat gliosarcoma using the p-boronophenylalanine-fructose complex. Int. J. Radiat. Oncol. Biol. Phys. 30, 643-652 (1994).
40. S. D. Kennedy, L. S. Szczepaniak, S. L. Gibson, R. Hilf, T. H. Foster, R. G. Bryant, Quantitative MRI of Gd-DTPA uptake in tumors: response to photodynamic therapy, Magn. Reson. Med. 31, 292-301 (1994).
41. F. Blankenberg, F. K. Conley, J. Sayre, D. Enzmann, MR imaging in an experimental model of brain tumor immunotherapy. Am. J. Neurorad. 12, 543-548 (1991).